PDT Partners’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-43,953
| Closed | -$1.05M | – | 1016 |
|
2021
Q1 | $1.05M | Sell |
43,953
-142,418
| -76% | -$3.4M | 0.08% | 366 |
|
2020
Q4 | $2.72M | Buy |
186,371
+36,654
| +24% | +$535K | 0.18% | 215 |
|
2020
Q3 | $2.13M | Sell |
149,717
-46,523
| -24% | -$661K | 0.14% | 209 |
|
2020
Q2 | $2.89M | Buy |
196,240
+141,140
| +256% | +$2.08M | 0.2% | 170 |
|
2020
Q1 | $227K | Buy |
55,100
+12,600
| +30% | +$51.9K | 0.02% | 533 |
|
2019
Q4 | $204K | Buy |
42,500
+6,500
| +18% | +$31.2K | 0.01% | 645 |
|
2019
Q3 | $218K | Hold |
36,000
| – | – | 0.01% | 404 |
|
2019
Q2 | $234K | Hold |
36,000
| – | – | 0.01% | 356 |
|
2019
Q1 | $255K | Sell |
36,000
-9,400
| -21% | -$66.6K | 0.01% | 370 |
|
2018
Q4 | $221K | Buy |
45,400
+10,279
| +29% | +$50K | 0.01% | 394 |
|
2018
Q3 | $258K | Buy |
+35,121
| New | +$258K | 0.01% | 412 |
|
2015
Q4 | – | Sell |
-29,569
| Closed | -$233K | – | 1081 |
|
2015
Q3 | $233K | Buy |
+29,569
| New | +$233K | 0.01% | 1111 |
|
2013
Q3 | – | Sell |
-13,600
| Closed | -$141K | – | 1792 |
|
2013
Q2 | $141K | Buy |
+13,600
| New | +$141K | ﹤0.01% | 1419 |
|